Psoriasis Treatment Market Size & Share, by Drug Class (TNF Inhibitors, Interleukins Inhibitors); Type (Plaque Psoriasis, Psoriatic Arthritis); Route of Administration (Oral, Parenteral/systematic, Topical); Distribution Channel (Hospital, Retail Pharmacies, Online Pharmacies - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 4625
Published Date: Feb 14, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Psoriasis Treatment Landscape

LEO Pharma A/S
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Amgen Inc.
UCB S.A.
Merck & co. Inc.
Evelo Biosciences Inc.
Sun Pharmaceutical Industries ltd.
Johnson & Johnson Services Inc.
Navartis AG
AbbVie Inc.
Pfizer Inc.

Browse Key Market Insights with Data Illustration:

Psoriasis Treatment Market Size & Share, Growth Trends 2035

In the News

LEO Pharma – LEO Pharma receives positive CHMP opinion of adtralza for the treatment of adolescents with moderate-to-severe atopic dermatitis.
Amgen Inc. – Amgen announces positive top-line results from otzela phase 3 discreet study in moderate to severe genital psoriasis

Frequently Asked Questions (FAQ)

Increasing prevalence of psoriasis and high demand for the treatment amid pandemic are the major factors driving the growth of the market.

The market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 - 2033.

High cost of medication and fluctuation in disease condition are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are LEO Pharma A/S, Amgen Inc, UCB S.A., Merck & co., Evelo Biosciences Inc., Sun Pharmaceutical Industries ltd, Johnson & Johnson Services Inc., Navartis AG, AbbVie Inc., Pfizer Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by Drug class, by type, by route of administration, by distribution channel, and by region.

The plaque psoriasis segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Psoriasis Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the psoriasis treatment market?

What would be the CAGR of psoriasis treatment market over the forecast period?

What are the challenges affecting the psoriasis treatment market growth?

Which region will provide more business opportunities for growth of psoriasis treatment market in future?

Who are the major players dominating the psoriasis treatment market?

How are the company profiles selected?

What are the segments in the psoriasis treatment market?

Which segment captures the largest market size in drug class in the psoriasis treatment market?